Guardian Pharmacy Services, Inc. Stock Price, News & Analysis

Guardian Pharmacy Services (NYSE:GRDN) reported strong Q2 2025 financial results, with revenue increasing 15% year-over-year to $344.3 million. The company's resident count grew 12% to over 195,000, while Adjusted EBITDA reached $25.0 million.

The company expanded its footprint through strategic acquisitions in Wichita, KS and Seattle, WA, launched a new greenfield pharmacy in Naples, FL, and subsequently acquired Managed Healthcare Pharmacy in Oregon. Guardian also completed a non-dilutive secondary offering of 8.625 million shares, enhancing trading liquidity.

Based on strong H1 2025 performance, Guardian raised its full-year guidance, projecting revenue of $1.39-1.41 billion (up from $1.33-1.35 billion) and Adjusted EBITDA of $100.0-102.0 million (up from $97.0-101.0 million).

Guardian Pharmacy Services (NYSE:GRDN) has announced the acquisition of Managed Healthcare Pharmacy, a leading long-term care (LTC) pharmacy in Oregon. The strategic acquisition marks Guardian's first physical presence in Oregon and expands its Pacific Northwest footprint.

Managed Healthcare Pharmacy, established in 1991, operates in Eugene and Medford, serving assisted living facilities, behavioral health communities, and individuals with intellectual and developmental disabilities across Oregon and Washington. The existing leadership and staff will be retained, and the pharmacy will maintain its current name while benefiting from Guardian's centralized corporate support in areas including data analytics, HR, IT, and payor relations.

Guardian Pharmacy Services (NYSE:GRDN) has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close. The company will host a conference call at 4:30 PM ET to discuss the results.

Investors can access the conference call through an audio webcast on the company's investor relations website or by dialing (646) 564-2877 (U.S.) or +1 (800) 549-8228 (international) with conference ID "95006". A replay will be available for approximately 60 days following the call.

Guardian Pharmacy Services (NYSE: GRDN) announced the merger and relocation of Winyah Pharmacy and Preferred Care into a new state-of-the-art headquarters in Charleston, South Carolina, operating under Guardian Pharmacy of South Carolina. The new facility is nearly double the size of previous locations combined and features advanced automation systems, robotic dispensing machines, and an IV infusion therapy suite. The consolidation brings all employees under one roof and positions the company for expanded services and growth. As part of Guardian Pharmacy Services' network of over 50 pharmacies serving 7,000 LTC facilities nationwide, the local team focuses on customer service while benefiting from Guardian's centralized corporate support for functions like analytics, HR, and IT. The company plans additional hiring throughout the year to support its growth trajectory.

Guardian Pharmacy Services (NYSE: GRDN) has acquired Mercury Pharmacy Services, a leading long-term care (LTC) pharmacy in Mountlake Terrace, Washington. This strategic acquisition marks Guardian's first entry into Washington state and the Pacific Northwest region. Mercury Pharmacy Services, founded in 2001, is a major LTC pharmacy provider in the Seattle-Tacoma area, serving assisted living, skilled nursing, behavioral health communities, and individuals with developmental disabilities. The existing Mercury team will remain in place, operating under the same name. Guardian's business model allows local pharmacy teams to focus on customer service while its Corporate Support Team handles backend operations. Founded in 2004, Guardian has grown to over 50 pharmacies serving approximately 7,000 LTC facilities nationwide through organic growth and acquisitions.

Guardian Pharmacy Services (NYSE: GRDN) has announced the pricing of its underwritten public offering of 7.5 million shares of Class A common stock at $21.00 per share. The offering consists of 6,059,553 shares from selling stockholders and 1,440,447 shares from Guardian in a non-dilutive synthetic secondary transaction. The underwriters have a 30-day option to purchase an additional 1,125,000 shares.

The offering, expected to close on May 27, 2025, is structured as non-dilutive since Guardian will use all net proceeds to repurchase 1,440,447 shares of Class A common stock at the offering price less underwriting discount. The total number of outstanding shares will remain unchanged after completion. Raymond James leads the offering as bookrunning manager, with Stephens Inc. and Truist Securities as joint bookrunning managers.

Guardian Pharmacy Services (NYSE: GRDN) has announced a proposed underwritten public offering of 7.5 million shares of Class A common stock. The offering consists of 6,059,553 shares from selling stockholders and 1,440,447 newly issued shares from Guardian. The underwriters will have a 30-day option to purchase an additional 1,125,000 shares.

The offering is structured as a non-dilutive "synthetic secondary" transaction, where Guardian will use all net proceeds to repurchase an equal number of Class A shares from certain stockholders at the public offering price less underwriting discount. This ensures the total outstanding shares remain unchanged. Raymond James leads the offering as bookrunning manager, with Stephens Inc. and Truist Securities acting as joint bookrunning managers.

Guardian Pharmacy Services (NYSE: GRDN) has announced the acquisition of Senior Care Pharmacy in Wichita, Kansas, expanding its long-term care (LTC) pharmacy services footprint in the Midwest. The acquisition strengthens Guardian's presence in south central and southwest Kansas, marking its second pharmacy location in the state alongside its Kansas City operation.

The Wichita location will maintain its existing name, leadership team, and staff, with Michael Counts, president of Guardian's Kansas City pharmacy, overseeing both locations. The acquired pharmacy will benefit from Guardian's local management business model and centralized Corporate Support Team services, including data analytics, HR, IT, and payor relations.

Founded in 2004, Guardian has grown to 52 pharmacies across 38 states through organic expansion, greenfield startups, and acquisitions.

Guardian Pharmacy Services (NYSE: GRDN) reported strong Q1 2025 financial results, with revenue reaching $329.3 million, up 20% year-over-year. The company's resident count increased 15% to 189,000, while net income grew by $2.2 million to $9.3 million. Adjusted EBITDA rose 16% to $23.4 million.

The growth was driven by organic expansion and recent acquisitions, including Heartland Pharmacy and Freedom Pharmacy. Guardian completed another acquisition in Wichita, Kansas on April 1, 2025, bringing its total pharmacy count to 52. The company maintains a strong financial position with $14.0 million in cash and no long-term debt.

Guardian reaffirmed its 2025 guidance, expecting revenue between $1.330-1.350 billion and Adjusted EBITDA of $97-101 million.